The dawn of targeted therapy for primary myelofibrosis: opportunities and challenges

Leuk Res. 2007 Jul;31(7):883-6. doi: 10.1016/j.leukres.2007.01.001. Epub 2007 Feb 15.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Primary Myelofibrosis / drug therapy*

Substances

  • Antineoplastic Agents